To be or not to be exclusive: the sutezolid story

Lancet Glob Health. 2016 Feb;4(2):e89-90. doi: 10.1016/S2214-109X(15)00285-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / economics*
  • Antitubercular Agents / therapeutic use
  • Drug Costs*
  • Drug Industry / economics*
  • Health Services Accessibility / economics*
  • Humans
  • Intellectual Property
  • Oxazolidinones / economics*
  • Oxazolidinones / therapeutic use
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antitubercular Agents
  • Oxazolidinones
  • PNU-100480